soteriabiotherapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-Agent: * Disallow: | ||
Meta Tags
| Title | Home - Soteria |
| Description | Developing switchable bispecific T-cell engagers to fight Skip to content About Expand About Us Leadership Board of Directors Scientific Advisory Board Investors Technology Expand Technology Overview Publications |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 72.167.242.48 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
soteriabiotherapeutics.com Valuation
|
US$5,591,950
Last updated: 2022-06-23 11:48:44
soteriabiotherapeutics.com has Semrush global rank of 1,892,775. soteriabiotherapeutics.com has an estimated worth of US$ 5,591,950, based on its estimated Ads revenue. soteriabiotherapeutics.com receives approximately 645,225 unique visitors each day. Its web server is located in United States, with IP address 72.167.242.48. According to SiteAdvisor, soteriabiotherapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$5,591,950 |
| Daily Ads Revenue | US$5,162 |
| Monthly Ads Revenue | US$154,854 |
| Yearly Ads Revenue | US$1,858,248 |
| Daily Unique Visitors | 43,015 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| soteriabiotherapeutics.com. 3599 IN | A | IP: 72.167.242.48 | |
| soteriabiotherapeutics.com. 21600 IN | NS | NS Record: ns-cloud-c3.googledomains.com. | |
| soteriabiotherapeutics.com. 21600 IN | NS | NS Record: ns-cloud-c2.googledomains.com. | |
| soteriabiotherapeutics.com. 21600 IN | NS | NS Record: ns-cloud-c4.googledomains.com. | |
| soteriabiotherapeutics.com. 21600 IN | NS | NS Record: ns-cloud-c1.googledomains.com. | |
| soteriabiotherapeutics.com. 3600 IN | MX | MX Record: 0 soteriabiotherapeutics-com.mail.protection.outlook.com. | |
| soteriabiotherapeutics.com. 3600 IN | TXT | TXT Record: MS=ms94704684 | |
| soteriabiotherapeutics.com. 3600 IN | TXT | TXT Record: google-site-verification=7rWOVheMkR64tN8SX1tLLjCvtARYOo7uIXDkwj5ffVg | |
| soteriabiotherapeutics.com. 3600 IN | TXT | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2022-06-23 11:48:44
| Skip to content About Expand About Us Leadership Board of Directors Scientific Advisory Board Investors Technology Expand Technology Overview Publications Newsroom Careers Contact Toggle Menu Developing switchable bispecific T-cell engagers to fight cancer Who we are We are an immuno-oncology company developing a next generation of bispecific T-cell engagers to treat patients with solid tumor cancers. Our mission is to safely harness the body’s natural immune system to defeat cancer and transform patients’ lives. LEARN MORE Our technology Our pioneering T-LITE™ platform provides switchable activation of bispecific antibody therapies, enabling safer and more efficacious treatments through pulsatile activity, reduced side effects and higher dosing. LEARN MORE Latest news May 17, 2021 Soteria Biotherapeutics Launches with $42 Million Series A Financing Led by Roche Venture Fund and 5AM Ventures Nov 12, 2020 Soteria Biotherapeutics Announces Scientific Advisory Board © 2022 Soteria |
HTTP Headers
HTTP/1.1 301 Moved Permanently Age: 0 Content-Security-Policy: upgrade-insecure-requests Content-Type: text/html; charset=iso-8859-1 Date: Sun, 24 Oct 2021 10:02:59 GMT Location: https://soteriabiotherapeutics.com/ Vary: User-Agent, Accept-Encoding X-Backend: local X-Cache: uncached X-Cache-Hit: MISS X-Cacheable: NO:HTTPS Redirect HTTP/2 200 server: openresty date: Sun, 24 Oct 2021 10:03:00 GMT content-type: text/html; charset=UTF-8 content-length: 61156 accept-ranges: bytes age: 76551 content-security-policy: upgrade-insecure-requests strict-transport-security: max-age=300 vary: Accept-Encoding, User-Agent x-backend: local x-cache: cached x-cache-hit: HIT x-cacheable: YES:Forced x-content-type-options: nosniff x-xss-protection: 1; mode=block strict-transport-security: max-age=31536000; includeSubDomains |
soteriabiotherapeutics.com Whois Information
Domain Name: SOTERIABIOTHERAPEUTICS.COM Registry Domain ID: 2238120874_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.google.com Registrar URL: http://domains.google.com Updated Date: 2021-06-03T19:41:22Z Creation Date: 2018-03-12T06:43:22Z Registry Expiry Date: 2022-03-12T06:43:22Z Registrar: Google LLC Registrar IANA ID: 895 Registrar Abuse Contact Email: registrar-abuse@google.com Registrar Abuse Contact Phone: +1.8772376466 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-CLOUD-C1.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-C2.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-C3.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-C4.GOOGLEDOMAINS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T17:54:25Z <<< |